Stay updated on Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page adds an NIH grant/contract note to the study identifiers and updates the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.6.5 appears on the page, replacing the previous v3.6.4, signaling a routine site update.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision indicator updates from v3.6.3 to v3.6.4, reflecting a new revision entry in the document history.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page now displays Revision: v3.6.3 in the footer, replacing the previous v3.6.2. This indicates a small update to the page's version metadata.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision tag v3.6.2 was added and the older v3.6.0 tag was removed. This reflects a minor version update in the page's revision history.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and indicates that no participants are being recruited. The Intervention/Treatment label is updated from 'Intervention / Treatment' and the revision version changes to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Nivolumab with Bevacizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Bevacizumab in Glioblastoma Clinical Trial page.